Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
The Milwaukee Journal Sentinel wants to know how the price of groceries is affecting your household. As the holiday shopping season gets into full swing, many shoppers are coping with buying gifts on ...
The Journal Sentinel's John Steppe and Ben Steele discuss Wisconsin's 96-76 win over Marquette, which was UW's biggest win in the rivalry since 1952. Where is the public betting in Week 15 of the NFL ...
Who will be the Milwaukee Journal Sentinel boys basketball player of the year? You tell us. Vote in our reader poll once per hour per device between now and Dec. 10 at noon to let us know who you ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Miami-based real estate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback